Mamoune A, Saraux A, Delaunay J L, Le Goff P, Youinou P, Le Corre R
Laboratory of Immunology, Unit of Rheumatology, Institut de Synergie des Sciences et de la Santé, Brest University Medical School, Brest, France.
J Autoimmun. 1998 Oct;11(5):485-8. doi: 10.1006/jaut.1998.0225.
Western blotting with U937 cell extracts as the substrate, and enzyme-linked immunosorbent assays (ELISA) with U937-, Jurkat- and Daudi cell-purified CD45 molecules were used to detect anti-CD45 reactivity in patients with systemic lupus erythematosus (SLE). By immunoblotting, 16 of 64 SLE sera were shown to be positive (25.0%). In the ELISAs, 13 out of 18 SLE sera reacted with the target CD45. Of these, three were not detectable on the blot. Importantly, 12 of these ELISA-positive sera contained IgM and IgG auto-antibodies. Neuraminidase-treatment of U937-precipitated CD45 molecules enhanced the reactivity to most of the isoforms, indicating that the antibodies may bind to asialylated polysaccharides.
以U937细胞提取物为底物进行蛋白质免疫印迹法,并采用U937、Jurkat和Daudi细胞纯化的CD45分子进行酶联免疫吸附测定(ELISA),以检测系统性红斑狼疮(SLE)患者的抗CD45反应性。通过免疫印迹法,64份SLE血清中有16份呈阳性(25.0%)。在ELISA中,18份SLE血清中有13份与目标CD45发生反应。其中,3份在印迹上未检测到。重要的是,这些ELISA阳性血清中有12份含有IgM和IgG自身抗体。对U937沉淀的CD45分子进行神经氨酸酶处理可增强对大多数异构体的反应性,表明这些抗体可能与去唾液酸化的多糖结合。